C/O: Thomas Ferencz R.Ph., BCOP

New Haven, Connecticut 06510

0 studies enrolling now · 1 studies all time

What they study most

Castration-Resistant Prostate Cancer

Studies at this site

• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed